IHT Wealth Management LLC Sells 359 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

IHT Wealth Management LLC cut its stake in shares of Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 11.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,906 shares of the company’s stock after selling 359 shares during the period. IHT Wealth Management LLC’s holdings in Addus HomeCare were worth $387,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Texas Permanent School Fund Corp increased its holdings in Addus HomeCare by 0.6% in the 2nd quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock worth $1,636,000 after purchasing an additional 82 shares in the last quarter. Arizona State Retirement System boosted its stake in shares of Addus HomeCare by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock valued at $527,000 after purchasing an additional 87 shares during the last quarter. UMB Bank n.a. boosted its position in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares during the last quarter. Inspire Investing LLC grew its holdings in Addus HomeCare by 3.3% during the 3rd quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after acquiring an additional 100 shares during the period. Finally, New York State Teachers Retirement System raised its position in shares of Addus HomeCare by 1.2% in the 3rd quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock worth $1,132,000 after acquiring an additional 100 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $120.74 on Monday. Addus HomeCare Co. has a 1 year low of $85.94 and a 1 year high of $136.12. The stock has a market capitalization of $2.19 billion, a P/E ratio of 27.63, a P/E/G ratio of 2.16 and a beta of 1.01. The company has a 50-day moving average price of $126.26 and a 200-day moving average price of $124.16.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same period in the previous year, the company posted $1.03 EPS. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. As a group, equities research analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ADUS shares. KeyCorp assumed coverage on Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company. Oppenheimer raised their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Tuesday, December 3rd. Macquarie restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $131.63.

Get Our Latest Stock Analysis on ADUS

Insider Activity at Addus HomeCare

In other news, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares in the company, valued at $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the transaction, the director now directly owns 3,366 shares in the company, valued at $429,165. The trade was a 12.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by insiders.

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.